Literature DB >> 18494694

Passenger behaviors during norovirus outbreaks on cruise ships.

Antonio J Neri1, Elaine H Cramer, George H Vaughan, Jan Vinjé, Hugh M Mainzer.   

Abstract

BACKGROUND: Norovirus causes a majority of outbreaks of gastrointestinal (GI) illness on cruise ships calling on the United States. Control measures include patient isolation, hand washing, and facility closure. Little is known about the behaviors and practices of people who have become ill with norovirus GI illness compared to those who remained well during an outbreak.
METHODS: Passenger surveys were distributed during three cruise ship outbreaks caused by norovirus. Surveys inquired about illness symptoms, ill contacts, illness reporting status, hand sanitation beliefs and practices, and availability of public hand sanitizer. A case was a passenger reporting three or more episodes of loose stool in a 24-hour period, three or more episodes of vomiting in a 24-hour period, or one or more episodes each of loose stool and vomiting in a 24-hour period. Controls reported that they were not ill during the cruise.
RESULTS: In total, 1,323 responses were compared. All ships had passengers who were ill prior to embarkation. Most cases delayed or did not report their illness to the ship's infirmary because they did not believe it was serious (43%-70% of responses). Cases were less likely to believe that isolation was effective in preventing disease spread [Mann-Whitney-Wilcoxon (MWW) p value <0.0001]. Cases were less likely to believe that hand washing or hand sanitizer are effective means of preventing disease spread (MWW p values 0.002 and 0.04, respectively), wash their hands after restroom use (MWW p value 0.02), or believe that hand sanitizer was available for public use prior to/after knowing about an outbreak (MWW p values 0.002 and 0.03, respectively).
CONCLUSIONS: Prevention and control of norovirus GI illness may be improved by routine screening of embarking passengers, education about GI illness and its impact on public health, a focus on improving hand-washing practices, and identification of public hand sanitizer dispensing locations.

Entities:  

Mesh:

Year:  2008        PMID: 18494694     DOI: 10.1111/j.1708-8305.2008.00199.x

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  6 in total

Review 1.  Norovirus outbreaks on commercial cruise ships: a systematic review and new targets for the public health agenda.

Authors:  Fabrizio Bert; Giacomo Scaioli; Maria Rosaria Gualano; Stefano Passi; Maria Lucia Specchia; Chiara Cadeddu; Cristina Viglianchino; Roberta Siliquini
Journal:  Food Environ Virol       Date:  2014-05-17       Impact factor: 2.778

Review 2.  Toward a systems approach to enteric pathogen transmission: from individual independence to community interdependence.

Authors:  Joseph N S Eisenberg; James Trostle; Reed J D Sorensen; Katherine F Shields
Journal:  Annu Rev Public Health       Date:  2012-01-03       Impact factor: 21.981

3.  An outbreak of Cyclospora infection on a cruise ship.

Authors:  R A Gibbs; R Nanyonjo; N M Pingault; B G Combs; T Mazzucchelli; P Armstrong; G Tarling; G K Dowse
Journal:  Epidemiol Infect       Date:  2012-06-12       Impact factor: 4.434

4.  Quantifying the relative effects of environmental and direct transmission of norovirus.

Authors:  S Towers; J Chen; C Cruz; J Melendez; J Rodriguez; A Salinas; F Yu; Y Kang
Journal:  R Soc Open Sci       Date:  2018-03-07       Impact factor: 2.963

5.  Self-reported stomach upset in travellers on cruise-based and land-based package holidays.

Authors:  Naomi J Launders; Gordon L Nichols; Rodney Cartwright; Joanne Lawrence; Jane Jones; Christos Hadjichristodoulou
Journal:  PLoS One       Date:  2014-01-10       Impact factor: 3.240

6.  Gastroenteritis outbreaks on cruise ships: contributing factors and thresholds for early outbreak detection.

Authors:  Varvara A Mouchtouri; Eleni Verykouki; Dumitru Zamfir; Christos Hadjipetris; Hannah C Lewis; Christos Hadjichristodoulou
Journal:  Euro Surveill       Date:  2017-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.